CLS is testing critical support at $400 within a macro uptrend. While currently correcting below the 50D SMA with negative momentum, the RSI (46) and 'Accumulate' signal suggest the selling is overextended. With strong analyst backing ($557 target) and a forward P/E of 23, the risk/reward is favorable. We enter at current prices near S1, placing a tight stop below S2/psychological support, targeting a rebound to Resistance 2.